Dr. Yamamoto is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
13280 Evening Creek Dr S
Ste 110
San Diego, CA 92128Phone+1 858-546-3800Fax+1 858-546-3900
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Radiology-Diagnostic, 2013 - 2017
University of California (San Francisco) School of MedicineInternship, Transitional Year, 2011 - 2012
David Geffen School of Medicine at UCLAClass of 2011
Certifications & Licensure
AZ State Medical License 2019 - 2027
MT State Medical License 2023 - 2027
AR State Medical License 2021 - 2026
VA State Medical License 2018 - 2026
TN State Medical License 2019 - 2026
PA State Medical License 2017 - 2026
OK State Medical License 2019 - 2026
American Board of Radiology Diagnostic Radiology- Join now to see all
Publications & Presentations
PubMed
- Retracted: Chest digital dynamic radiography to detect changes in human pulmonary perfusion in response to alveolar hypoxia.Shota Yamamoto, Fumio Sakamaki, Genki Takahashi, Yusuke Kondo, Naoya Taguchi
Journal of Medical Radiation Sciences. 2023-12-01 - Short- and long-term efficacy of bronchial artery embolization using a gelatin sponge for the treatment of cryptogenic hemoptysis.Naoko Nagano, Manabu Suzuki, Shota Yamamoto, Konomi Kobayashi, Motoyasu Iikura
Global Health & Medicine. 2022-12-31 - 1 citationsDose length product and outcome of CT fluoroscopy-guided interventions using a new 320-detector row CT scanner with deep-learning reconstruction and new bow-tie filter.Tomohiro Matsumoto, Kazuyuki Endo, Shota Yamamoto, Satoshi Suda, Kosuke Tomita
The British Journal of Radiology. 2022-08-01
Press Mentions
The Impact of Bronchial Artery Embolisation on the Quality of Life of Patients with Haemoptysis: A Prospective Observational StudyJanuary 6th, 2021- Impact of the Catechol-O-methyltransferase Val158Met Polymorphism on the Pharmacokinetics of L-dopa and Its Metabolite 3-O-methyldopa in Combination with EntacaponeNovember 2nd, 2020
The Co-Creator of Prey, Duke Nukem, and Max Payne Wants to Kill You with Vitamin SupplementsOctober 5th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
